Earmark - Therapeutic Approaches to Anthrax & Ricin Toxins

Agency:		Department of Defense--Military
Bureau:		Research, Development, Test, and Evaluation
Account:		Research, development, test, and evaluation, Defense-wide (97-0400)
Certifying Official:		Deputy Comptroller Program/Budget
Contact Information:		http://WWW.DOD.GOV 703-697-5131

Therapeutic Approaches to Anthrax & Ricin Toxins

1 recipient will receive $2,000,000.

Year Enacted: 2005

Description: USAMRIID, The Department of Defense and BioShield have a high priority need for solutions to threats from Ebola virus, Marburg virus, Ricin toxin and Anthrax. The intent is to utilize AVI BioPharma proprietary technologies to provide, where possible, the

Beneficiary/Recipient	Amount ($K)	Program	Type	Address
Unconventional Concepts Inc	$2,000		For-Profit	Mary Ester, FL

Citation

Source: Appropriations Report Language - Conference

Reference: 108-622

Location: Line 8, Page 340

Citation Excerpt: Therapeutic Approaches to Anthrax & Ricin Toxins

Last Modified: 16-Apr-2007